Underreporting of suspected adverse drug reactions to newly marketed (“black triangle”) drugs in general practice: observational study von Martin, Richard M, Kapoor, Karan V, Wilton, Lynda V, Mann, Ronald D

Volltext

Safety of Long‐Term Lamotrigine in Epilepsy von Mackay, F. J., Wilton, L. V., Peace, G. L., Freemantle, S. N., Mann, R. D.

Volltext

Safety profile of orlistat: results of a prescription-event monitoring study von Acharya, N.V, Wilton, L.V, Sharkir, S.A.W

Volltext

Cardiovascular events in users of sildenafil: results from first phase of prescription event monitoring in England von Shakir, Saad A W, Wilton, Lynda V, Boshier, Andrew, Layton, Deborah, Heeley, Emma

Volltext

Evaluation of the safety of sildenafil for male erectile dysfunction: experience gained in general practice use in England in 1999 von Boshier, A., Wilton, L.V., Shakir, S.A.W.

Volltext

The outcomes of pregnancy in women exposed to newly marketed drugs in general practice in England von Wilton, L. V., Pearce, G. L., Martin, R. M., Mackay, F. J., Mann, R. D.

Volltext

The safety of valsartan: results of a postmarketing surveillance study on 12 881 patients in England von BISWAS, P. N, WILTON, L. V, SHAKIR, S. W

Volltext

A comparison of ciprofloxacin, norfloxacin, ofloxacin, azithromycin and cefixime examined by observational cohort studies von WILTON, L. V., PEARCE, G. L., MANN, R. D.

Volltext

Visual field defect associated with vigabatrin: observational cohort study von Wilton, L V, Stephens, M D B, Mann, R D

Volltext

The pharmacovigilance of olanzapine: results of a post-marketing surveillance study on 8858 patients in England von Biswas, Pipasha N., Wilton, Lynda V., Pearce, Gillian L., Freemantle, Shayne, Shakir, Saad A. W.

Volltext

Ron Mann's scientific contributions as the second Director of the DSRU von Shakir, SAW, LV, Wilton

Volltext

Prescription-event monitoring and reporting of adverse drug reactions von Heeley, Emma, Riley, Jane, Layton, Deborah, Wilton, Lynda V, Shakir, Saad AW

Volltext

Comments to regional problems of analgesic risk perception von Hudec, R, Wilton, L V, Kriska, M

Volltext

Losartan: a study of pharmacovigilance data on 14,522 patients von Mann, R, Mackay, F, Pearce, G, Freemantle, S, Wilton, L

Volltext

A comparison of two cohort studies evaluating the safety of cisapride : Prescription-Event Monitoring and a large phase IV study von WAGER, E, TOOLEY, P. J. H, PEARCE, G. L, WILTON, L. V, MANN, R. D

Volltext

Troglitazone and liver function abnormalities: Lessons from a prescription Event monitoring study and spontaneous reporting von BISWAS, Pipasha, WILTON, Lynda V, SHAKIR, Saad A

Volltext

Profiles of hepatic and dysrhythmic cardiovascular events following use of fluoroquinolone antibacterials: Experience from large cohorts from the Drug Safety Research Unit Prescrip... von CLARK, David W. J, LAYTON, Deborah, WILTON, Lynda V, PEARCE, Gillian L, SHAKIR, Saad A. W

Volltext

A Postmarketing Surveillance Study of Gabapentin as Add‐on Therapy for 3,100 Patients in England von Wilton, Lynda V., Shakir, Saad

Volltext

Comparative study of mortality rates and cardiac dysrhythmias in post-marketing surveillance studies of sertindole and two other atypical antipsychotic drugs, risperidone and olanz... von Wilton, Lynda V., Heeley, Emma L., Pickering, Ruth M., Shakir, Saad A.

Volltext

Pharmacovigilance study of alendronate in England von BISWAS, Pipasha N, WILTON, Lynda V, SHAKIR, Saad A. W

Volltext